Cargando…
Remdesivir Efficacy in COVID-19 Treatment: A Randomized Controlled Trial
To date, no antiviral therapy has shown proven clinical effectiveness in treating patients with COVID-19. We assessed the efficacy of remdesivir in hospitalized Egyptian patients with COVID-19. Patients were randomly assigned at a 1:1 ratio to receive either remdesivir (200 mg on the first day follo...
Autores principales: | Abd-Elsalam, Sherief, Salama, Marwa, Soliman, Shaimaa, Naguib, Ahmed Mohamed, Ibrahim, Ibrahim S., Torky, Mohamed, El Ghafar, Mohamed Samir Abd, Abdul-Baki, Enas Abdul-Raouf M., Elhendawy, Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922517/ https://www.ncbi.nlm.nih.gov/pubmed/34649223 http://dx.doi.org/10.4269/ajtmh.21-0606 |
Ejemplares similares
-
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
por: Dabbous, Hany M., et al.
Publicado: (2021) -
Retraction Note to: Efficacy of favipiravir in COVID‑19 treatment: a multi‑center randomized study
por: Dabbous, Hany M., et al.
Publicado: (2021) -
Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020) -
Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020) -
Response to “Randomized Controlled Trials on COVID-19 Should be Accurate and Trustworthy”
por: Abd-Elsalam, Sherief, et al.
Publicado: (2022)